Revista de bioingeniería y ciencia biomédica

Pathological Role of the "Invisible" Anastomoses

Abstract

Vladimir Ermoshkin

Thesis: An attempt to analyse the mechanism of cardiovascular disease (CVD). It is now believed that most heart disease of unknown etiologic and mechanism, with the CVD mortality is very high. Why theoretical medicine for over 100 years has such limited success? What is the true reason, for example, venous plethora?

Methods: Finding information in the literature, participation in medical conferences in Russia (2012-2016), as well as in Australia, Brisbane "Arrhythmia-2016", correspondence with scientists, discussions with leading Russian cardiologists, publication of my original articles.

Results: I was able to show that in modern theoretical cardiology there are significant errors. Our group with an instrument "Cardiocode" were able to confirm the presence of large arteriovenous anastomoses (AVA) in otherwise healthy people. The sudden opening of the lumen AVA causes a sharp drop in blood pressure.

When closing AVA, usually a few seconds, the blood pressure increases again. Such manipulations AVA, apparently provided by nature to protect the blood vessels from the peak pressure values. It turns out that the longterm "wrong" operation AVA, especially when an unhealthy lifestyle usually leads to two major problems.

First problem: The periodic disturbances of heart rhythm, sometimes with fatal outcome, due to excitation of the heart by means of a pulse of mechanical waves running through the contour of the vessels with the return of their heart. The second problem is: violation of "metabolism" of the prolonged increase in venous pressure as a systemic and local. This paper attempts to study the causes of venous plethora and diseases of the pelvic organs in humans.

Conclusions: I believe that, taking into account the vast experience of the modern official medicine, taking into account the large number of clinical observations, and using in the near future, the theory proposed by me might be able to make a breakthrough in the treatment of cardiovascular disease, including in the treatment of venous plethora.